Who owns QUALIGEN THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Qualigen Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Qualigen Therapeutics stock

Who bought or sold QUALIGEN THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Capital Management 246k $291k 1616% Jun 2026
 View chart
Geode Capital Management 131k $154k 86% Jun 2026
 View chart
Vanguard Fiduciary Trust 105k $124k 100% Jun 2026
 View chart
Citadel Advisors 67k $79k 100% Jun 2026
 View chart
Northern Trust 20k $24k 100% Jun 2026
 View chart
BlackRock 501.00 $590.979600 0% Jun 2026
 View chart
Barclays 444.00 $524.008800 100% Jun 2026
 View chart
Harbour Investments 325.00 $383.987500 0% Jun 2026
 View chart
HighMark Wealth Management 160.00 $188.000000 0% Jun 2026
 View chart
Group One Trading 8.00 $9.000000 0% Jun 2026
 View chart
SBI Securities 6.00 $7.000200 0% Jun 2026
 View chart
UMA Financial Services 2.00 $3.000000 0% Jun 2026
 View chart
Caitong International Asset Management 2.00 $2.000000 100% Jun 2026
 View chart
Danske Bank A/s 1.00 $1.000000 0% Jun 2026
 View chart

Who sold out of Qualigen Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Two Sigma Securities Mar 2026 14k $17k
Goldman Sachs Group Mar 2026 11k $14k
Us Bancorp Dec 2025 7.00 $15.999900